Medical Marijuana Companies Indifferent Towards THC Synthesis Development

Small quantities of THC, or tetrahydrocannabinol, the main chemical responsible for marijuana’s psychological effects, could be engineered from yeast, according to a paper published in August  by  scientists at the Technical University of Dortmund in Germany.

With New York recently permitting five select medical marijuana companies to open dispensaries across the state, these companies, along with medical marijuana companies all over the nation, now have the question of whether this development could be used to supplement their supplies of conventional marijuana.

PharmaCannis, one of the five companies selected to open up dispensaries in New York, will be required to open its doors at the beginning of 2016 in the counties of Hamptonburgh, Orange County as well as towns in the Bronx and Albany.

For PharmaCannis, there does not seem to be a use for synthetic THC since the company grows a sufficient amount of conventional marijuana, said Patty Park,  an...

Rate this article: 
Region: 

This marijuana news is brought to you by 420 Intel. For the latest breaking cannabis industry news, subscribe to the 420 Intel newsletter. If you'd like to promote your product or service in this area after every article, contact us.